REPROCELL invests in Histocell, S.L. a Spain-based CDMO Yokohama Japan, 23 November 2022: REPROCELL Inc. decided to invest in Histocell S.L. to strengthen its clinical induced pluripotent stem cell (iPSC) service offerings. Histocell is a CDMO based in Bilbao, Spain, with an authorized Advanced Therapy Medical Product (ATMP) manufacturing facility that offers GMP-grade manufacturing services for…
Incidences of Breast cancer (BC) are on rapid rise (by 39% over past two decades) making it the most common malignancy among Indian women. Epidemiology of breast cancer differs significantly in Indian women from Western population. Current trends point out that a higher proportion of the disease is occurring at a younger age in Indian…
Bioserve India granted NABL accreditation in the field of Genomics Testing Hyderabad, India, 3 August 2022: We are pleased to announce that Bioserve Biotechnologies India Pvt Ltd, a subsidiary of REPROCELL Inc, has received NABL (National Accreditation Board for Testing and Calibration Laboratories) Accreditation for Medical Testing in field of Genomics Testing Services. The accreditation…